Coronavirus Disease 2019 and Pediatric Asthma: Friend or foe?

Elissa M. Abrams


Curr Opin Allergy Clin Immunol. 2022;22(2):95-100. 

In This Article


The interplay of asthma and COVID-19 remains an evolving story and while it is yet to be fully elucidated, asthma appears to be more friend than foe. There is no evidence to date that asthma is a risk factor for more severe COVID-19 outcomes, especially in children. There is actually some basis to suggest that children with atopic asthma may be at reduced risk of asthma exacerbations during COVID-19. The impact of asthma therapeutics on COVID-19 outcomes is unclear, but guidance is relatively uniform in recommending that those with asthma remain on current asthma medications. A focus on social determinants of health may be increasingly important during the pandemic and beyond.